Novo Nordisk A/S ADR (NVO) Stock Price, Quote & News

Company Profile

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products i...

Industry: Drug Manufacturers - General

Sector: Healthcare

Phone: 45 44 44 88 88

Website: www.novonordisk.com

Address:

Novo Alle 1, Bagsvaerd, Denmark

bginvest Sep. 11 at 12:31 PM

$CNC $NVO $UNH CONGRATULATIONS 🏦 Now we’re only waiting for a bigger jump in Novo 📈👀💪

0 · Reply

B_LionShare Sep. 11 at 12:05 PM

Since initial call $NVO (+14%) | $CNC (+25%) | $UNH (+38%)

0 · Reply

oldmanrizzer Sep. 11 at 11:15 AM

$NVO Jesus, what now? This stock is cursed.

0 · Reply

israelgreen Sep. 11 at 11:02 AM

$NVO today is the start, were so close to it.

0 · Reply

bginvest Sep. 11 at 10:58 AM

$BTC.X $MSTR $NVDA $NVO $PLTR 65$ MAGNET 🧲 by end of the month or beginning of October 📈🧐✌️

0 · Reply

Marketwatcher71 Sep. 11 at 10:50 AM

$NVO 30$ magnet 🧲

0 · Reply

NYChichas Sep. 11 at 10:34 AM

$NVO The chart is clear on the price action. revisiting the Blue shaded area is only logical. Stoch RSI flashing buy is Logical too ( Hour chart )

0 · Reply

FRESH_OUT_OF_COLLEGE Sep. 11 at 10:25 AM

$NVO $45 MAGNET

0 · Reply

bginvest Sep. 11 at 10:13 AM

$NVO why is the USA 🇺🇸 inPRE market taking the price down everyday with only a small number of shares traded there can only be one reason someone are still not finished loading shares 🧐🤷🏻‍♂️

1 · Reply

Marketwatcher71 Sep. 11 at 9:34 AM

$NVO how is Novo possible. It’s the same price action almost every single day. Where is SEC? This is pure stock price manipulation and control.

0 · Reply

Novo Nordisk layoffs: 9,000 jobs cut as weight-loss drug competition with Eli Lilly heats up

Sep 10, 2025, 2:51 PM EDT - 17 hours ago

Ozempic maker to cut thousands of jobs

Sep 10, 2025, 2:49 PM EDT - 17 hours ago

Novo Nordisk: Restructuring And Reduced Guidance Set Up A Cleaner 2026

Sep 10, 2025, 2:22 PM EDT - 18 hours ago

Novo Nordisk to cut 9,000 jobs

Sep 10, 2025, 1:03 PM EDT - 19 hours ago

US tariffs, pricing risks to be manageable for Big Pharma, Morningstar says

ABBV AZN GSK NVS SNY AMGN LLY

Sep 10, 2025, 12:14 PM EDT - 20 hours ago

Novo Nordisk: Job Cuts, Profit Guidance Shock - Why Investors Should Hold Firm

Sep 10, 2025, 11:55 AM EDT - 20 hours ago

Novo Nordisk Cuts Around 9,000 Jobs as Weight-Loss Drugmaker Faces Growing Competition

Sep 10, 2025, 10:00 AM EDT - 22 hours ago

Novo Nordisk: Priced Like Best Days Are Over [Upgrade]

Sep 10, 2025, 9:24 AM EDT - 23 hours ago

Ozempic Maker Novo Nordisk to Cut 9,000 Jobs

Sep 10, 2025, 9:00 AM EDT - 23 hours ago

Our H2 2025 Top Ideas

AMZN ASML CB INTC LLY OXY QQQ

Sep 10, 2025, 6:32 AM EDT - 1 day ago

Novo Nordisk Cuts 9,000 Jobs and Slashes Guidance. Why the Stock Is Rising.

Sep 10, 2025, 5:00 AM EDT - 1 day ago

Wegovy maker Novo Nordisk to cut 9,000 jobs amid increased competition

Sep 10, 2025, 4:47 AM EDT - 1 day ago

Weight-loss drug manufacturer Novo Nordisk cuts 9000 jobs — and its profit forecast

Sep 10, 2025, 3:46 AM EDT - 1 day ago

Novo Nordisk cuts 9K jobs to save $1.26B amid Wegovy growth, Eli Lilly rivalry

Sep 10, 2025, 2:43 AM EDT - 1 day ago

Wegovy-maker Novo Nordisk to cut 9,000 jobs in restructuring

Sep 10, 2025, 1:18 AM EDT - 1 day ago

Wegovy-maker Novo Nordisk to cut around 9,000 jobs

Sep 10, 2025, 1:07 AM EDT - 1 day ago

Novo Nordisk to cut 9,000 jobs in restructuring

Sep 8, 2025, 10:18 AM EDT - 2 days ago

Ozempic Is The New Botox And Big Pharma Is Printing Billions

LLY

Sep 8, 2025, 9:58 AM EDT - 2 days ago

Novo Nordisk: A Pharma Leader With Growth Potential And Portfolio-Defensive Appeal

Sep 8, 2025, 2:43 AM EDT - 3 days ago

Novonesis and Novo Nordisk will explore new solutions to improve metabolic health

Sep 6, 2025, 10:09 AM EDT - 4 days ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Novo Nordisk

Sep 5, 2025, 6:10 PM EDT - 5 days ago

Novo Nordisk: Keep It Low So I Can Keep Accumulating (Rating Upgrade)

Sep 5, 2025, 1:10 PM EDT - 5 days ago

Novo Nordisk Vs Eli Lilly: Novo A Clear Winner

LLY

Sep 5, 2025, 2:01 AM EDT - 6 days ago

Novo Nordisk to present new semaglutide data on ‘food noise', body composition and cardiovascular benefits, as well as pipeline data at the EASD diabetes congress

Sep 4, 2025, 1:36 PM EDT - 6 days ago

Novo Nordisk Is a Strong Buy After the 2025 Pullback

Sep 3, 2025, 2:09 PM EDT - 7 days ago

Global drugmakers rush to boost US presence as tariff threat looms

ABBV AMGN AZN BIIB GILD JNJ LLY

Sep 3, 2025, 2:08 PM EDT - 7 days ago

Healthy Returns: Novo Nordisk's head of research and development previews the first-ever obesity pill

Sep 2, 2025, 5:00 AM EDT - 9 days ago

Phasecraft Raises $34 Million from Plural, Playground Global, and Novo Holdings to Bring Quantum Computing Closer to Solving Real-World Challenges

Sep 1, 2025, 9:05 AM EDT - 9 days ago

Wegovy trial result gives boost to Novo Nordisk amid U.S. market woes

Sep 1, 2025, 6:39 AM EDT - 10 days ago

Novo's Wegovy Beats Lilly's Zepbound for Heart Health, Study Finds. What It Means for Stocks.

LLY

Sep 1, 2025, 3:30 AM EDT - 10 days ago

Novo Nordisk Says Wegovy Cuts Heart Risk by 57% Compared With Eli Lilly's Obesity Drug

Aug 31, 2025, 12:30 PM EDT - 10 days ago

Novo Nordisk's Wegovy cuts heart risk by 57% versus rival Lilly weight-loss drug in study

Aug 31, 2025, 3:09 AM EDT - 11 days ago

Novo Nordisk's Wegovy® cuts risk of heart attack, stroke or death by 57% compared to tirzepatide in real-world study of people with obesity and cardiovascular diseas

Aug 31, 2025, 3:09 AM EDT - 11 days ago

Novo Nordisk's Wegovy® cuts risk of heart attack, stroke or death by 57% compared to tirzepatide in real-world study of people with obesity and cardiovascular disease

Aug 29, 2025, 8:37 AM EDT - 12 days ago

Denmark cuts growth forecast as Novo slowdown sparks reliance debate

Aug 29, 2025, 6:12 AM EDT - 13 days ago

Ozempic Maker Novo Nordisk Is a Problem as Denmark's Economy Hits a Wall

Aug 29, 2025, 3:11 AM EDT - 13 days ago

Denmark slashes 2025 growth forecast amid Novo Nordisk slowdown

Aug 28, 2025, 5:15 PM EDT - 13 days ago

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Novo Nordisk

Aug 28, 2025, 10:13 AM EDT - 13 days ago

Despite Early Low Awareness, Physicians Forecast Swift Adoption of Novo Nordisk's Wegovy in MASH, According to Spherix Global Insights

Aug 28, 2025, 8:19 AM EDT - 14 days ago

Novo Nordisk seeks new obesity, diabetes drugs with Replicate BioScience partnership

Aug 27, 2025, 8:30 AM EDT - 15 days ago

Form Health Selected for Novo Nordisk's NovoCare® Platform to Expand Access to Science-Based Obesity Care Across the United States

Aug 26, 2025, 5:00 PM EDT - 15 days ago

Novo Holdings Announces Sale of KabaFusion

Aug 24, 2025, 10:30 AM EDT - 17 days ago

Novo Nordisk: Undervalued Pharma Heavyweight With Upside Potential

bginvest Sep. 11 at 12:31 PM

$CNC $NVO $UNH CONGRATULATIONS 🏦 Now we’re only waiting for a bigger jump in Novo 📈👀💪

0 · Reply

B_LionShare Sep. 11 at 12:05 PM

Since initial call $NVO (+14%) | $CNC (+25%) | $UNH (+38%)

0 · Reply

oldmanrizzer Sep. 11 at 11:15 AM

$NVO Jesus, what now? This stock is cursed.

0 · Reply

israelgreen Sep. 11 at 11:02 AM

$NVO today is the start, were so close to it.

0 · Reply

bginvest Sep. 11 at 10:58 AM

$BTC.X $MSTR $NVDA $NVO $PLTR 65$ MAGNET 🧲 by end of the month or beginning of October 📈🧐✌️

0 · Reply

Marketwatcher71 Sep. 11 at 10:50 AM

$NVO 30$ magnet 🧲

0 · Reply

NYChichas Sep. 11 at 10:34 AM

$NVO The chart is clear on the price action. revisiting the Blue shaded area is only logical. Stoch RSI flashing buy is Logical too ( Hour chart )

0 · Reply

FRESH_OUT_OF_COLLEGE Sep. 11 at 10:25 AM

$NVO $45 MAGNET

0 · Reply

bginvest Sep. 11 at 10:13 AM

1 · Reply

Marketwatcher71 Sep. 11 at 9:34 AM

$NVO how is Novo possible. It’s the same price action almost every single day. Where is SEC? This is pure stock price manipulation and control.

0 · Reply

Linusnuss Sep. 11 at 9:12 AM

$NVO its just tiring. When is the presentation in Vienna again? Can’t stand the price action anymore

1 · Reply

Happiness77 Sep. 11 at 9:03 AM

$NVO Fucking everyday same pattern. Using EU market playing a trick and cheating

0 · Reply

pinkfloyd66 Sep. 11 at 6:49 AM

$NVO let’s have a f’ing 5% days red, we bulls all deserve it . Amen!

0 · Reply

IshinCuts Sep. 11 at 2:51 AM

$NVO TIMBER!!

1 · Reply

MoneyGroupLLC Sep. 11 at 2:37 AM

Enter: $NVO OCT 03 2025 $55 CALLS Buy in Price: $2.03 - $2.16 Take Profit: $2.96 Stop Bleeding: $1.90 ROI Potential: 37% Exit Within: 58 Minutes https://moneygroup.us/alerts

0 · Reply

someguyfromthefutur Sep. 11 at 1:44 AM

$NVO Let it begin…

0 · Reply

BobWeaver83 Sep. 10 at 11:55 PM

$NVO Happy with my stack, but will add more under 50.

0 · Reply

Willieberich Sep. 10 at 11:34 PM

$NVO 54 and under is a buy .added a few hundred today as I did yesterday ..good luck people .be kind to each other .don't fall into the hate !!!

0 · Reply

DocPharm Sep. 10 at 10:21 PM

$ABUS likely for one of Genevant’s partners They have a ton of codeveloped products - it sounds like at least one is showing promise $NVO $BNTX $EDIT $TAK come to mind firstly

1 · Reply

Dtheman31 Sep. 10 at 10:12 PM

$NVO Lower gap filled and closed above VWAP on Copenhagen Exchange. Time to go..

1 · Reply

AfroJoe Sep. 10 at 10:04 PM

$NVO Marjorie Taylor Green and other politicians are buying here

0 · Reply

ice_man7 Sep. 10 at 8:37 PM

$NVO when $60

1 · Reply

Market Cap	242.45B
Revenue (ttm)	42.11B
Net Income (ttm)	14.64B
EPS (ttm)	N/A
PE Ratio	14.67
Forward PE	14.11
Profit Margin	34.78%
Debt to Equity Ratio	0.59

Volume	16,488,200
Avg Vol	17,513,824
Day's Range	N/A - N/A
Shares Out	4.47B
Stochastic %K	34%
Beta	0.66
Analysts	Sell
Price Target	$65.88